Alpha-mangostin decreases high glucose-induced damage on human umbilical vein endothelial cells by increasing

Farhad Eisvand1, Kasra Rezvani1, Hossein Hosseinzadeh1,2

  • 1Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Insights

Alpha-mangostin protects against high glucose damage in cells by reducing oxidative stress and enhancing autophagy. This natural compound offers potential therapeutic benefits for diabetes complications.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Diabetes mellitus is a metabolic disorder characterized by impaired glucose metabolism and hyperglycemia.
  • Hyperglycemia induces oxidative stress, disrupting the balance between reactive oxygen species (ROS) and antioxidant enzymes, leading to cellular damage.
  • Autophagy, a cellular degradation process, is crucial for maintaining cellular health but can be impaired under high glucose conditions, leading to the accumulation of damaged components.

Purpose of the Study:

  • To investigate the protective effects of alpha-mangostin (A-MG) on high glucose-induced autophagic dysfunction in human umbilical vein endothelial cells (HUVECs).
  • To evaluate the impact of A-MG on cell viability, oxidative stress markers (ROS and NO), and key autophagy-related proteins (LC3, SIRT1, beclin 1) under hyperglycemic conditions.

Main Methods:

  • HUVECs were exposed to varying concentrations of glucose (5-60 mM) and A-MG (1.25-10 μM) for three days.
  • Cell viability, ROS, and nitric oxide (NO) content were measured in HUVECs treated with 60 mM glucose and 2.5 μM A-MG.
  • Western blot analysis was employed to quantify the expression levels of autophagy proteins LC3, SIRT1, and beclin 1.

Main Results:

  • High glucose (60 mM) significantly reduced HUVEC viability and increased ROS and NO levels.
  • Exposure to high glucose led to decreased expression of autophagy proteins LC3, SIRT1, and beclin 1.
  • A-MG treatment counteracted the detrimental effects of high glucose, restoring cell viability and increasing the levels of essential autophagy proteins.

Conclusions:

  • Alpha-mangostin demonstrates significant cytoprotective effects against high glucose-induced damage in HUVECs.
  • A-MG mitigates oxidative stress by reducing ROS and NO generation.
  • A-MG enhances the autophagic pathway, as evidenced by increased expression of key autophagy-related proteins, suggesting its potential as a therapeutic agent for diabetic complications.